Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

New blood cancer treatment appears successful for most trial patients

December 12, 2022 Research and Development

A new and experimental immunotherapy treatment has appeared successful in treating patients with multiple myeloma in an ongoing phase 1/2 …
News

Positive results for BioVie’s Parkinson’s and Alzheimer’s phase 2 trials

December 6, 2022 Research and Development

BioVie has announced positive results from two phase 2 trials which have been assessing NE3107’s efficacy in treating Parkinson’s Disease …
News
national-cancer-institute-uurfmwa25f0-unsplash

Nkarta data supports natural killer cells in cancer treatment

December 6, 2022 Research and Development

San Francisco, US-based Nkarta have been assessing the power of natural killer (NK) cells in oncology treatments. The treatment is …
News

Innovent Biologics and UNION Therapeutics announce first dosing of Chinese subject in phase 1 study

December 5, 2022 Research and Development

Innovent Biologics, a biopharmaceutical company which develops, manufactures and commercialises medicines for the treatment of illnesses within the scope of …
News

Amgen’s obesity drug appears promising with few side effects

December 5, 2022 Research and Development

Amgen Inc’s new obesity drug has appeared promising in its small phase 1 trial, meaning they will be able to …
News

New insights into HIV vaccine revealed by researchers

December 5, 2022 Research and Development

Although researchers have previously always struggled to develop an efficient HIV vaccine, the results of a first-in-human clinical trial for …
News

GSK’s two new cancer drugs look promising

December 2, 2022 Research and Development

GlaxoSmithKline (GSK) appear to be making some positive progress in their oncology department, with drugs for both myelofibrosis and endometrial …
News

Elon Musk’s Neuralink to conduct human trials in 2023

December 1, 2022 Research and Development

Neuralink owner Elon Musk announced that he has submitted paperwork to the FDA which he hopes will allow Neuralink to …
News

Stem cell transplants could be offered to MS patients in new trial

November 30, 2022 Research and Development

In a world-first trial, the University of Sheffield and Sheffield Teaching Hospital NHS Foundation Trust will investigate the efficacy of …
News

Collaboration between BioNTech and Ryvu Therapeutics to develop and commercialise immuno-modulatory small molecule candidates

November 30, 2022 Research and Development

Ryvu Therapeutics, a clinical-stage oncology therapeutics development company, has announced a collaboration with BioNTech, which will consist of two parts: …
News

New Alzheimer’s drug, lecanemab slows disease but divides opinions

November 30, 2022 Research and Development

Japanese drugmaker Eisai and its US partner Biogen have announced that their new drug to treat Alzheimer’s disease appeared to …
News

RadNet’s Aidence AI subsidiary and Google Health enter into agreement to bring lung cancer screening model to market

November 30, 2022 Research and Development

Aidence, an AI subsidiary of RadNet which looks at lung health, has partnered with Google Health to license Google Health’s …
News

University of Texas and Novartis Pharmaceuticals develop new computer platform for easier drug discovery

November 29, 2022 Research and Development

Researchers from both the University of Texas, US and Novartis Pharmaceuticals have developed a computer-based platform which appears to make …
News

Two-dose chemotherapy drug enters clinical trial for cancer patients

November 28, 2022 Research and Development

South Korean biotech firm Hyundai Bioscience’s innovative chemotherapy drug may be able to complete cancer treatments in two doses. The …
News

Lunit first SaMD in APAC region to secure CE mark and UKCA certification for AI-based radiology solution

November 23, 2022 Research and Development

Lunit, a South Korean medical software company, has become the first software as a medical device (SaMD) company in the …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026